JORGE BELGODERE-BONILLA: Open Payments
NPI 1841306255 · BROUSSARD, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 8 payments from 5 companies in 2025. Trend: 2023 $425 · 2024 $527 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $49 |
| ABBVIE INC. | 2 | $37 |
| Indivior Inc. | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: KISUNLA, QULIPTA, SUBLOCADE, VRAYLAR, ACCRUFER, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
